Skip to main content
Intended for healthcare professionals
Restricted access
Research article
First published online September 2, 2021

Antimicrobial resistance: The fundamental role of primary care

Abstract

Antimicrobial resistance (AMR) develops when microbes, such as bacteria, evolve to no longer be susceptible to an antimicrobial agent. AMR is a huge concern, being regarded internationally as one of the current top 10 threats to global health. By 2050, it is predicted that AMR will be responsible for more deaths globally than cancer. Countries around the world are rising to the challenge of reducing antimicrobial resistance, and primary care has a key role in this objective, as the vast majority of antibiotic prescribing takes place in the community. This article will explore the challenges facing primary care clinicians regarding antimicrobial stewardship and will consider approaches in day-to-day general practice that can help tackle AMR, including a number of helpful and easy to use resources. Future considerations and innovative technologies will also be discussed.

Get full access to this article

View all access and purchase options for this article.

References and further information

Armitage R, Nellums L (2020) Antibiotic prescribing in general practice during COVID-19. Lancet Infectious Diseases 21(6): E144DOI: 10.1016/S1473-3099(20)30917-8.
Balinskaite V, Bou-Antoun S, Johnson AP, et al.(2018) An assessment of potential unintended consequences following a national antimicrobial stewardship program in England: An interrupted time series analysis. Clinical Infectious Diseases 69(2): 233–242. DOI: 10.1093/cid/ciy904.
Bejaoui S, Poulsen M (2020) The impact of early life antibiotic use on atopic and metabolic disorders: Meta-analyses of recent insights. Evolution, Medicine and Public Health 24(1): 279–289. DOI: 10.1093/emph/eoaa039.
Costelloe C, Metcalfe C, Lovering A, et al.(2010) Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis. British Medical Journal 340: c2096DOI: 10.1136/bmj.c2096.
Francis NA, Butler CC, Hood K, et al.(2009) Effect of using an interactive booklet about childhood respiratory tract infections in primary care consultations on reconsulting and antibiotic prescribing: A cluster randomised controlled trial. British Medical Journal 339: b2885DOI: 10.1136/bmj.b2885.
Gharbi M, Drysdale JH, Lishman H, et al.(2019) Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all-cause mortality: Population based cohort study. British Medical Journal 364: l525DOI: 10.1136/bmj.l525.
Gulliford MC, Moore MV, Little P, et al.(2016) Safety of reduced antibiotic prescribing for self-limiting respiratory tract infections in primary care: Cohort study using electronic health records. British Medical Journal 354: i3410DOI: 10.1136/bmj.i3410.
Gwaltney JM Jr (1996) Acute community-Acquired sinusitis. Clinical Infectious Diseases 23(6): 1209–1225. DOI: 10.1093/clinids/23.6.1209.
Khalid TY, Duncan LJ, Thornton HV, et al. (2021) Novel multi-virus rapid respiratory microbiological point-of-care testing in primary care: A mixed-methods feasibility evaluation. Family Practice. Epub ahead of print 4 March 2021. DOI: 10.1093/fampra/cmab002.
Langford BJ, So M, Raybardhan S, et al.(2021) Antibiotic prescribing in patients with COVID-19: Rapid review and meta-analysis. Clinical Microbiology and Infection 27(4): 520–531. DOI: 10.1016/j.cmi.2020.12.018.
Little P, Hobbs FR, Moore M, et al.(2013a) Clinical score and rapid antigen detection test to guide antibiotic use for sore throats: Randomised controlled trial of PRISM (primary care streptococcal management). British Medical Journal 347: f5806DOI: 10.1136/bmj.f5806.
Little P, Moore M, Kelly J, et al.(2014) Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: Pragmatic, factorial, randomised controlled trial. British Medical Journal 348: g1606DOI: 10.1136/bmj.g1606.
Little P, Stuart B, Francis N, et al.(2013b) Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: A multinational, cluster, randomised, factorial, controlled trial. The Lancet 382(9899): 1175–1182. DOI: 10.1016/S0140-6736(13)60994-0.
Moore M, Stuart B, Hobbs FR, et al.(2017) Influence of the duration of penicillin prescriptions on outcomes for acute sore throat in adults: The DESCARTE prospective cohort study in UK general practice. British Journal of General Practice 67(662): e623–e633. DOI: 10.3399/bjgp17X692333.
NICE (2014) Pneumonia in adults: Diagnosis and management. Available at: www.nice.org.uk/guidance/cg191 (accessed 3 March 2021).
NICE and PHE (2020) Summary of antimicrobial prescribing guidance – managing common infections. Available at: www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/antimicrobial-prescribing-guidelines (accessed 3 March 2021).
O'Neill J (2016) Tackling drug-resistant infections globally: Final report and recommendations. The review on antimicrobial resistance. Available at: https://amr-review.org/Publications.html (accessed 3 March 2021).
Oduwole O, Udoh EE, Oyo-Ita A, et al. Honey for acute cough in children. Cochrane Database of Systematic Reviews 20184: artno.: CD007094. DOI: 10.1002/14651858.CD007094.pub5.
Petersen I, Johnson AM, Islam A, et al.(2007) Protective effect of antibiotics against serious complications of common respiratory tract infections: Retrospective cohort study with the UK General Practice Research Database. British Medical Journal 335(7627): 982DOI: 10.1136/bmj.39345.405243.BE.
PHE (2020) English surveillance programme for antimicrobial utilisation and resistance (ESPAUR), 2019 to 2020. Available at: www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report (accessed 3 March 2021).
Pouwels KB, Hopkins S, Llewelyn MJ, et al.(2019) Duration of antibiotic treatment for common infections in English primary care: Cross sectional analysis and comparison with guidelines. British Medical Journal 364: l440DOI: 10.1136/bmj.l440.
Rawson TM, Moore LSP, Zhu N, et al.(2020) Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clinical Infectious Diseases 71(9): 2459–2468. DOI: 10.1093/cid/ciaa530.
RCGP. Clinical topic guide: Respiratory health. Available at: www.rcgp.org.uk/training-exams/training/gp-curriculum-new/clinical-topic-guides/respiratory-health.aspx (accessed 21 June 2021).
Skoog Ståhlgren G, Tyrstrup M, Edlund C, et al.(2019) Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: Randomised controlled, open label, non-inferiority study. British Medical Journal 367: l5337DOI: 10.1136/bmj.l5337.
Smieszek T, Pouwels KB, Dolk FCK, et al.(2018) Potential for reducing inappropriate antibiotic prescribing in English primary care. Journal of Antimicrobial Chemotherapy 73(suppl_2): ii36–ii43. DOI: 10.1093/jac/dkx500.
Thornton HV, Khalid T, Hay AD (2020) Point-of-care testing for respiratory infections during and after COVID-19. British Journal of General Practice 70(701): 574–575. DOI: 10.3399/bjgp20X713561.
UK Government (2019a) Tackling antimicrobial resistance 2019–2024. The UK’s five-year national action plan. Available at: www.gov.uk/government/publications/uk-5-year-action-plan-for-antimicrobial-resistance-2019-to-2024 (accessed 3 March 2021).
UK Government (2019b) Contained and controlled. The UK’s 20-year vision for antimicrobial resistance. Available at: www.gov.uk/government/publications/uk-20-year-vision-for-antimicrobial-resistance (accessed 3 March 2021).
World Health Organisation (2015) Global action plan on antimicrobial resistance. Available at: www.who.int/publications/i/item/9789241509763 (accessed 21 June 2021).